Monte Rosa Therapeutics, Inc. · NASDAQ:GLUE
Bowen Matthew sold 13 Monte Rosa Therapeutics, Inc. shares (Form 4)
Traded Oct 5, 2026 · Filed Oct 6, 2026
On Oct 5, 2026, Bowen Matthew (Principal Accounting Officer) sold 13 Monte Rosa Therapeutics, Inc. shares at US$10.56 for US$137, leaving 25,891 shares. Filed Oct 6, 2026 (Form 4).
- Sold
- 13 shares
- Price
- US$10.56
- Value
- US$137
- Holding after
- 25,891 shares
- Trading plan
- No
- Role
- Principal Accounting Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 5, 2026 | Common Stock | Sale | 13 | US$10.56 | 25,891 | Direct |
Source
Related
- Monte Rosa Therapeutics, Inc.
- Bowen Matthew
- Monte Rosa Therapeutics, Inc. shareholders
- Form 4 · Bowen Matthew · Apr 7, 2026
- Schedule 13G/A · Montanova Capital, LLC · Aug 14, 2026
- Schedule 13G · Vestal Point Capital, LP · Aug 14, 2026
- Form 4 · Warmuth Markus · Jul 17, 2026
- Form 4 · Champoux Jennifer · Jul 16, 2026
- Schedule 13G/A · T. Rowe Price Associates Inc · Jul 8, 2026